Marc van Dijk
Company: MiNK Therapeutics New!
Job title: Chief Scientific Officer
Seminars:
Panel: The Future of Allogeneic Cell Therapies in Autoimmune Indications & Beyond 1:30 pm
View the full event guide for more detailsRead more
day: B O Bootcamp Day
Combatting Infectious Disease with Allogeneic Invariant NK Cell Therapies 10:30 am
View the full event guide for more detailsRead more
day: B O Bootcamp Day
Identifying Novel Cancer Biomarkers that Indicate Responsiveness to Allogeneic Cell Therapies 11:30 am
View the full event guide for more detailsRead more
day: Pre-Clinical Track Day Two AM